Related Experiment Video
Updated: Nov 17, 2025

07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
11.6K
Relationship Between Pregnancy and Acute Disseminated Encephalomyelitis: A Single-Case Study
Shuwen Deng1, Ke Qiu2, Ranran Tu1
1Department of Neurology, The Second Xiangya Hospital, Central South University, Changsha, China.
Frontiers in Immunology
|February 18, 2021
Summary
Pregnancy-related acute disseminated encephalomyelitis (ADEM) involves immune changes at the maternal-fetal interface. The HMGB1/TLR4/Nf-κB/IL-6 pathway activation may contribute to ADEM pathogenesis during pregnancy.
Area of Science:
- Immunology
- Neuroscience
- Obstetrics & Gynecology
Background:
- The link between pregnancy and autoimmune diseases like ADEM is not well understood.
- Investigating the maternal-fetal interface is crucial for understanding pregnancy-related neurological conditions.
Purpose of the Study:
- To explore the role of local immune responses and the HMGB1/TLR4/Nf-κB/IL-6 pathway in pregnancy-related ADEM.
- To analyze dynamic changes in lymphocyte populations and molecular markers post-abortion in an ADEM patient.
Main Methods:
- Case study involving a patient with pregnancy-related ADEM.
- Flow cytometry for lymphocyte subset analysis.
- Real-time qPCR and Western blotting to assess gene and protein expression (HMGB1, TLR4, Nf-κB, AQP4, IL-2, IL-6) in placental and fetal membrane tissues.
Main Results:
- The ADEM patient showed increased B lymphocytes and decreased NKT lymphocytes.
- Elevated expression of HMGB1, TLR4, Nf-κB, AQP4, and IL-6 was observed in the placenta and fetal membranes of the ADEM patient compared to a normal pregnancy.
- Lower IL-2 expression was noted in the ADEM patient.
Conclusions:
- Local immune alterations and activation of the HMGB1/TLR4/Nf-κB/IL-6 pathway at the maternal-fetal interface are implicated in the pathogenesis of pregnancy-related ADEM.
- These findings highlight potential therapeutic targets for managing ADEM during pregnancy.
Keywords:
Immune ToleranceT-helper lymphocytesacute disseminated encephalomyelitisimmunological pathogenesispregnancy
